146 related articles for article (PubMed ID: 36669893)
21. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit.
Reffelmann T; Kloner RA
Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H1099-107. PubMed ID: 12181140
[TBL] [Abstract][Full Text] [Related]
22. Assessment of coronary microcirculation alterations in a porcine model of no-reflow using ultrasound localization microscopy: a proof of concept study.
Demeulenaere O; Mateo P; Ferrera R; Chiaroni PM; Bizé A; Dai J; Sambin L; Gallet R; Tanter M; Papadacci C; Ghaleh B; Pernot M
EBioMedicine; 2023 Aug; 94():104727. PubMed ID: 37487415
[TBL] [Abstract][Full Text] [Related]
23. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
Jaffe R; Dick A; Strauss BH
JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
[TBL] [Abstract][Full Text] [Related]
24. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.
Hausenloy DJ; Chilian W; Crea F; Davidson SM; Ferdinandy P; Garcia-Dorado D; van Royen N; Schulz R; Heusch G
Cardiovasc Res; 2019 Jun; 115(7):1143-1155. PubMed ID: 30428011
[TBL] [Abstract][Full Text] [Related]
25. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.
Yip HK; Chen MC; Chang HW; Hang CL; Hsieh YK; Fang CY; Wu CJ
Chest; 2002 Oct; 122(4):1322-32. PubMed ID: 12377860
[TBL] [Abstract][Full Text] [Related]
26. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.
Rochitte CE; Lima JA; Bluemke DA; Reeder SB; McVeigh ER; Furuta T; Becker LC; Melin JA
Circulation; 1998 Sep; 98(10):1006-14. PubMed ID: 9737521
[TBL] [Abstract][Full Text] [Related]
27. No reflow phenomenon in coronary heart disease.
Ito H
J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
[TBL] [Abstract][Full Text] [Related]
28. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.
Roe MT; Ohman EM; Maas AC; Christenson RH; Mahaffey KW; Granger CB; Harrington RA; Califf RM; Krucoff MW
J Am Coll Cardiol; 2001 Jan; 37(1):9-18. PubMed ID: 11153779
[TBL] [Abstract][Full Text] [Related]
29. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.
Reffelmann T; Hale SL; Li G; Kloner RA
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H766-72. PubMed ID: 11788428
[TBL] [Abstract][Full Text] [Related]
30. Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion.
Niccoli G; Celestini A; Calvieri C; Cosentino N; Falcioni E; Carnevale R; Nocella C; Fracassi F; Roberto M; Antonazzo RP; Pignatelli P; Crea F; Violi F
Eur Heart J Acute Cardiovasc Care; 2013 Dec; 2(4):379-88. PubMed ID: 24338297
[TBL] [Abstract][Full Text] [Related]
31. Microvascular integrity after reperfusion therapy.
Agati L
Am Heart J; 1999 Aug; 138(2 Pt 2):S76-8. PubMed ID: 10426863
[TBL] [Abstract][Full Text] [Related]
32. Early temporal changes in coronary flow velocity patterns in patients with acute myocardial infarction demonstrating the "no-reflow" phenomenon.
Iwakura K; Ito H; Nishikawa N; Hiraoka K; Sugimoto K; Higashino Y; Masuyama T; Hori M; Fujii K; Minamino T
Am J Cardiol; 1999 Aug; 84(4):415-9. PubMed ID: 10468079
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Microvascular Reperfusion After Myocardial Infarction.
Doherty DJ; Sykes R; Mangion K; Berry C
Curr Cardiol Rep; 2021 Feb; 23(3):21. PubMed ID: 33624185
[TBL] [Abstract][Full Text] [Related]
34. State of the Art: No-Reflow Phenomenon.
Caiazzo G; Musci RL; Frediani L; Umińska J; Wanha W; Filipiak KJ; Kubica J; Navarese EP
Cardiol Clin; 2020 Nov; 38(4):563-573. PubMed ID: 33036718
[TBL] [Abstract][Full Text] [Related]
35. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction.
Tanaka A; Kawarabayashi T; Nishibori Y; Sano T; Nishida Y; Fukuda D; Shimada K; Yoshikawa J
Circulation; 2002 May; 105(18):2148-52. PubMed ID: 11994247
[TBL] [Abstract][Full Text] [Related]
36. Myocardial no-reflow in humans.
Niccoli G; Burzotta F; Galiuto L; Crea F
J Am Coll Cardiol; 2009 Jul; 54(4):281-92. PubMed ID: 19608025
[TBL] [Abstract][Full Text] [Related]
37. Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow.
Nakamura S; Takehana K; Sugiura T; Hatada K; Hamada S; Asada J; Yuyama R; Mimura J; Imuro Y; Kurihara H; Fukui M; Baden M; Iwasaka T
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):383-9. PubMed ID: 12634966
[TBL] [Abstract][Full Text] [Related]
38. Assessing the relation between coronary reflow and myocardial reflow.
Ito H; Iwakura K
Am J Cardiol; 1998 Jun; 81(12A):8G-12G. PubMed ID: 9662220
[TBL] [Abstract][Full Text] [Related]
39. Etiology and clinical implications of microvascular dysfunction in patients with acute myocardial infarction.
Ito H
Int Heart J; 2014; 55(3):185-9. PubMed ID: 24806384
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion.
Han B; Zhang X; Zhang Q; Zhao G; Wei J; Ma S; Zhu W; Wei M
Arch Cardiovasc Dis; 2011 May; 104(5):313-24. PubMed ID: 21693368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
